Ioannis S. Patrikios, George N. Loukaides, Evangelia E. Ntzani & Marios C. Pantzaris. A Pioneer Nutraceutical Formula (PLP10) for the Treatment of Relapsing Remitting Multiple Sclerosis: A Randomized, Double Blind, Placebo Controlled Proof-of-Concept Clinical Trial. Dietetic Association & AODA Regional Conference, 2012. http://www.palupamedical.com/resources/Nutrition-page-71.pdf
NEWS
2nd American Society for Nutrition Middle East Congress
Ioannis S. Patrikios, George N. Loukaides, Evangelia E. Ntzani & Marios C. Pantzaris. A novel oral medical nutrition formula (PLP10) for the treatment of relapsing remitting multiple sclerosis: a randomized, double-blind, placebocontrolled proof-of-concept clinical trial. AJCN, ASN; 2nd American Society for Nutrition Middle East Congress. Dubai, 2013 https://www.nutrition.org/education-and-professional-development/archived-content-from-past-meetings-and-professional-development-events/2nd-american-society-for-nutrition-middle-east-congress/
Pharma Nutrition journal-Elsevier
Ioannis S. Patrikios, George N. Loukaides, Evangelia E. Ntzani & Marios C. Pantzaris. Pioneer oral nutraceutical formula (PLP10) for the treatment of relapsing remitting multiple sclerosis: A randomized, double-blind, placebocontrolled proof-of-concept clinical trial. Pharma Nutrition journal-Elsevier; Singapore, 2013
http://www.pharma-nutrition.com/resources/downloads/Oral%20Program%20-%2019.03.2013.pdf
Neurobiology, Psychopharmacology & Treatment Guidance – ICNP2013
Ioannis S. Patrikios, George N. Loukaides, Evangelia E. Ntzani & Marios C. Pantzaris. A novel oral medical nutrition formula (PLP10) for the treatment of relapsing-remitting multiple sclerosis: a randomized, double-blind, placebo-controlled proof-of-concept clinical trial to the 3rd International Congress on Neurobiology, Psychopharmacology & Treatment Guidance (Thessaloniki Greece, 2013)
26th Hellenic Congress of Greek Neurologists
Marios C. Pantzaris, George N. Loukaides, Evangelia E. Ntzani & Ioannis S. Patrikios. A novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomized, double-blind, placebo-controlled proof-of-concept clinical trial. Greek Neurological Society, Thessaloniki 2013 (link: http://www.enee.gr/en/images/conf/2013_06_20_26th_congr_ene/2013_06_20_26th_congr_ene.pdf)
1st Multidisciplinary Scientific Bio-Medical Symposium/Congress “Bio-medical Scientific Cyprus”
Ioannis S. Patrikios, George N. Loukaides, Evangelia E. Ntzani & Marios C. Pantzaris. Systems Medicine, a Novel Approach to Chronic Diseases: the example of PLP10 Multiple Sclerosis intervention treatment, a phase II clinical trial. Biomedical Scientific Cyprus, 2013. https://www.google.com.cy/#q=the+example+of+PLP+10+Multiple+Sclerosis+intervention+treatment,+a+phase+II+clinical+trial.+Biomedical+Scientific+Cyprus,+2013
6th International Conference on Drug Discovery and Therapy
Ioannis S. Patrikios, George N. Loukaides, Evangelia E. Ntzani & Marios C. Pantzaris. Systems Medicine, Applying Systems Biology Approaches for Multiple Sclerosis Treatment by the Use of Specific Structured Μolecules and Antioxidant Vitamins: the PLP10 Novel Ιntervention Paradigm; 6th International Conference on Drug Discovery and Therapy, Dubai 2014.
Trends in Drug Research
Ioannis S. Patrikios, George .N. Loukaides, Evangelia E. Ntzani, Marios C. Pantzaris. Systems Medicine, Applying Systems Biology Approaches for Manipulation of Altered Biomechanisms towards Multiple Sclerosis Treatment by the Use of Specific Structured molecules and Antioxidant Vitamins: the PLP10 intervention Paradigm. Trends in Drug Research 05/2014; 32:87-102. DOI:ISBN 978-9963-9615-3-5
http://www.quintessence.com.cy/?wp=trends-2014-home, http://www.quintessence.com.cy/?wp=trends-2014-invited-speakers
2nd Panhellenic Congress of the Hellenic Academy of NeuroImmunology on Multiple Sclerosis.
Ioannis S. Patrikios, George N. Loukaides, Marios C. Pantzaris; Specific Omega3, Omega-6 Polyunsaturated Fatty Acids and γ-Tocopherol in the Therapy of Relapsing Multiple Sclerosis: the Paradigm of the PLP10 Intervention Efficacy and Correlation to the Molecular Alteration of the Red blood Cells’ Membranes; Neuroimmunology, Thessaloniki, 2014 https://www.researchgate.net/publication/266079759_Specific_Omega-3_Omega-6_Polyunsaturated_Fatty_Acids_and_g-Tocopherol_in_the_Therapy_of_Relapsing_Multiple_Sclerosis_the_Paradigm_of_the_PLP10_Intervention_Efficacy_and_Correlation_to_the_Molecular_Al
NEUROASPIS® plp10 at the 31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis
NEUROASPIS® plp10 was presented at ECTRIMS 2015 (http://onlinelibrary.ectrims-congress.eu/ectrims/2015/31st/115778/undefined)
S. Patrikios, G.N. Loucaides, M. Pantzaris, M.A. Crawford, K. Ghebremeskel; Omega-3, Omega-6 PUFA and gamma-Tocopherol in multiple sclerosis: PLP10 intervention efficacy and red blood cells’ membrane lipids composition